Audit of FDA Inspections of Genericmakers Planned by OIG for 2015

Drug Industry Daily
An HHS watchdog will audit how the FDA inspects generics manufacturing facilities, oversees postmarketing studies and ensures compliance with clinical trial reporting requirements, as well as how the drug industry is implementing the track-and-trace law.

To View This Article:


Subscribe To Drug Industry Daily